Want to see CLYM full AI Analyst Report?
CLYM Analyst Ratings
Strong Buy
13 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
CLYM Stock 12 Month Forecast
Average Price Target
$21.56
▲(135.32% Upside)
| Highest Price Target$35.00 | Average Price Target$21.56 | Lowest Price Target$17.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$20
Buy
118.34%
Upside
Reiterated
06/24/26
Raymond James
―
Buy
―
Reiterated
06/24/26
Leerink Partners
―
Buy
―
Reiterated
06/12/26
Wedbush
$17
Buy
85.59%
Upside
Reiterated
06/12/26
BTIG
$19→$20
Buy
118.34%
Upside
Reiterated
06/11/26
William Blair
―
Buy
―
Reiterated
06/11/26
Guggenheim
$35
Buy
282.10%
Upside
Initiated
06/08/26
Truist Financial
―
Buy
―
Reiterated
06/02/26
Piper Sandler
$23
Buy
151.09%
Upside
Reiterated
05/19/26
Oppenheimer
$18
Buy
96.51%
Upside
Reiterated
05/15/26
Robert W. Baird
$12→$21
Buy
129.26%
Upside
Reiterated
05/06/26
Chardan Capital
$22
Buy
140.17%
Upside
Reiterated
05/05/26
Mizuho Securities
$18
Buy
96.51%
Upside
Initiated
04/15/26
B. Riley Securities
$26
Buy
183.84%
Upside
Initiated
03/24/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$20
Buy
118.34%
Upside
Reiterated
06/24/26
Raymond James
―
Buy
―
Reiterated
06/24/26
Leerink Partners
―
Buy
―
Reiterated
06/12/26
Wedbush
$17
Buy
85.59%
Upside
Reiterated
06/12/26
BTIG
$19→$20
Buy
118.34%
Upside
Reiterated
06/11/26
William Blair
―
Buy
―
Reiterated
06/11/26
Guggenheim
$35
Buy
282.10%
Upside
Initiated
06/08/26
Truist Financial
―
Buy
―
Reiterated
06/02/26
Piper Sandler
$23
Buy
151.09%
Upside
Reiterated
05/19/26
Oppenheimer
$18
Buy
96.51%
Upside
Reiterated
05/15/26
Robert W. Baird
$12→$21
Buy
129.26%
Upside
Reiterated
05/06/26
Chardan Capital
$22
Buy
140.17%
Upside
Reiterated
05/05/26
Mizuho Securities
$18
Buy
96.51%
Upside
Initiated
04/15/26
B. Riley Securities
$26
Buy
183.84%
Upside
Initiated
03/24/26
Best Analysts Covering Climb Bio
3 Months
Success Rate
5/5 ratings generated profit
Average Return
+91.36%
Copying Leland Gershell's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +91.36% per trade.
1 Year
Success Rate
7/7 ratings generated profit
Average Return
+445.24%
Copying Julian Harrison's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +445.24% per trade.
2 Years
Success Rate
8/8 ratings generated profit
Average Return
+507.65%
Copying Thomas Smith's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +507.65% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
CLYM Analyst Recommendation Trends
Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
8
11
18
16
13
Buy
7
5
12
13
13
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
16
30
29
26
Each month's total comprises the sum of three months' worth of ratings.
CLYM Financial Forecast
CLYM Stock Forecast FAQ
What is CLYM’s average 12-month price target, according to analysts?
Based on analyst ratings, Climb Bio, Inc.’s 12-month average price target is 21.56.
What is CLYM’s upside potential, based on the analysts’ average price target?
Climb Bio, Inc. has 135.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is CLYM a Buy, Sell or Hold?
Climb Bio, Inc. has a consensus rating of Strong Buy which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.
What is Climb Bio, Inc.’s price target?
The average price target for Climb Bio, Inc. is 21.56. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $35.00 ,the lowest forecast is $17.00. The average price target represents 135.32% Increase from the current price of $9.16.
The highest analyst price target is $35.00 ,the lowest forecast is $17.00. The average price target represents 135.32% Increase from the current price of $9.16.
What do analysts say about Climb Bio, Inc.?
Climb Bio, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of CLYM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.